These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects. Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612 [TBL] [Abstract][Full Text] [Related]
7. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients. Ko GN; Korpi ER; Kirch DG J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607 [TBL] [Abstract][Full Text] [Related]
8. Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics. Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Hu WH; Chien CP; Lam YF; Jann MW Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):105-12. PubMed ID: 8416597 [TBL] [Abstract][Full Text] [Related]
9. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo. Eklund K; Forsman A Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310 [TBL] [Abstract][Full Text] [Related]
10. Haloperidol dosing requirements: the contribution of smoking and nonlinear pharmacokinetics. Perry PJ; Miller DD; Arndt SV; Smith DA; Holman TL J Clin Psychopharmacol; 1993 Feb; 13(1):46-51. PubMed ID: 8486817 [TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients. Ulrich S; Sandmann U; Genz A Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420 [TBL] [Abstract][Full Text] [Related]
12. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial. Goff DC; Arana GW; Greenblatt DJ; Dupont R; Ornsteen M; Harmatz JS; Shader RI J Clin Psychopharmacol; 1991 Apr; 11(2):106-12. PubMed ID: 2056136 [TBL] [Abstract][Full Text] [Related]
13. Relation of plasma and red blood cells reduced haloperidol concentrations to haloperidol reductase activity assayed in red blood cells in psychiatric population. Shibasaki M; Someya T; Takahashi S Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar; 17(2):257-67. PubMed ID: 8430218 [TBL] [Abstract][Full Text] [Related]
14. Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients. Ereshefsky L; Davis CM; Harrington CA; Jann MW; Browning JL; Saklad SR; Burch NR J Clin Psychopharmacol; 1984 Jun; 4(3):138-42. PubMed ID: 6736273 [TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. Chouinard G; Annable L; Campbell W J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086 [TBL] [Abstract][Full Text] [Related]
16. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report. Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368 [TBL] [Abstract][Full Text] [Related]
17. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses. Roose K Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558 [TBL] [Abstract][Full Text] [Related]
18. Dose-dependent reduced haloperidol/haloperidol ratios: influence of patient-related variables. Lane HY; Chang WH; Chang YC; Hu OY; Lin HN; Jann MW; Hu WH Psychiatry Res; 1997 Sep; 72(2):127-32. PubMed ID: 9335203 [TBL] [Abstract][Full Text] [Related]
19. Serum haloperidol concentrations and clinical response in acute psychosis. Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996 [TBL] [Abstract][Full Text] [Related]
20. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]